Trans-spinal direct current stimulation (tsDCS) can help improve walking and reduce fatigue for people with multiple sclerosis (MS).
In a study with people who have MS, those who received tsDCS showed better walking abilities than those who did not receive this treatment. Specifically, they walked faster and felt less tired after the sessions. The tsDCS group improved their walking times on tests that measure how quickly they can walk short distances. They also reported feeling less fatigue in their daily activities. Overall, this treatment appears to make a significant difference in both walking and energy levels.
MS patients who struggle with walking and feel tired often could find tsDCS helpful in their day-to-day lives. Just like using crutches can support someone who has a leg injury, tsDCS might provide the extra boost needed to walk better and feel less fatigued. Caregivers can also benefit from this knowledge, as helping their loved ones manage fatigue and mobility can improve everyone's quality of life. Healthcare providers may consider adding tsDCS to their treatment plans to better support patients. Overall, these findings could lead to more effective ways to manage MS symptoms.
The study involved a small group of 22 people, so more research is needed to confirm these results on a larger scale. Not everyone may respond the same way to tsDCS, and some people might not see improvement. It's important for patients to discuss this treatment option with their healthcare provider to see if it’s right for them.
12/1/2025
Learn how the PHH-1V booster shot could provide better COVID protection for MS patients and their ca
Read More12/1/2025
Learn how anti-NMDAR encephalitis overlaps with MS and what it means for treatment and symptom manag
Read More12/1/2025
Discover how dignity affects family caregivers of MS patients and why their feelings matter for bett
Read More12/1/2025
Learn how studying certain viral genes in our DNA may lead to better MS treatments and improve sympt
Read More12/1/2025
Discover how gut bacteria may boost cognitive function in MS patients and why gut health matters for
Read More12/1/2025
Discover how targeting Piezo1 in immune cells could change MS management and improve symptoms for pa
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurologic physical therapy : JNPT often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.